Medical Management of Inflammatory Bowel Disease in the New Millennium

Author： Lombardi Daniel A.   Feller Edward R.   Shah Samir A.  

Publisher： Humana Press, Inc

ISSN： 0098-8243

Source： Comprehensive Therapy, Vol.28, Iss.1, 2002-03, pp. : 39-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Inflammatory Bowel Disease Using Stem Cell Therapy

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 1, 2016-01 ,pp. : 72-77

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Inflammatory Bowel Disease Using Stem Cell Therapy

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 1, 2016-01 ,pp. : 72-77

Bentham Science Publishers

Access to resources Recommend Favorite

Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease

By Fellermann K.   Herrlinger K.R.   Witthoeft T.   Homann N.   Ludwig D.   Stange E.F.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2247-2248

Elsevier

Access to resources Recommend Favorite

PPAR and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease

By Wada K.   Nakajima A.   Blumberg R.S.  

Trends in Molecular Medicine, Vol. 7, Iss. 8, 2001-08 ,pp. : 329-331

Elsevier

Access to resources Recommend Favorite

Inflammatory bowel disease (Crohn's disease) in a Spanish patient with pars plana exudates: Report of a new case and review of the literature

By Gorroño-Echebarría Marina B.   Albarrán Fernando   Marcos Ama   Alvarez-Mon Melchor  

Ocular Immunology and Inflammation, Vol. 10, Iss. 1, 2002-03 ,pp. : 65-68

Informa Healthcare

Access to resources Recommend Favorite